Civic Intelligence

The Gerson Research Organization

990EZ • Fiscal year 2017 • EIN 33-0588751

Jan 01, 2017 to Dec 31, 2017 • Filed on Nov 12, 2018

Organization ProfileN/A
7807 Artesian RoadSan Diego, CA 92127

(858) 774-6642

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

95th percentile

1.01x

Higher debt load relative to assets than 95% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Liabilities / Revenue

84th percentile

0.13x

Higher debt load relative to revenue than 84% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Net Margin

73rd percentile

17%

Higher net margin than 73% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Top Officer Pay

88th percentile

$36,580

Higher top officer pay than 88% of similar nonprofits.

Top officer pay equals 34.4% of source-year revenue.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Asset Growth

98th percentile

521%

Faster asset growth than 98% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Revenue Growth

86th percentile

53%

Faster revenue growth than 86% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Balance Sheet
Liabilities / Assets95th percentile

Assets

Up

$13,255

Up $11,120 (+521%) from 2016

Net Assets

Up

-$134

Up $18,195 (+99%) from 2016

Liabilities

Down

$13,389

Down $7,075 (-35%) from 2016

Revenue And Expenses
Liabilities / Revenue84th percentileNet Margin73rd percentile

Revenue

Up

$106,375

Up $36,938 (+53%) from 2016

Expenses

Down

$88,180

Down $5,966 (-6.3%) from 2016

Net Income

Up

$18,195

Up $42,904 (+174%) from 2016

Historical Trend

Balance Sheet Trend

Asset Growth98th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100K$50K$0-$50KAssets 2013: $2,293Liabilities 2013: $12,965Net Assets 2013: -$10,6722013Assets 2014: $35,526Liabilities 2014: $12,965Net Assets 2014: $22,5612014Assets 2015: $19,345Liabilities 2015: $12,965Net Assets 2015: $6,3802015Assets 2016: $2,135Liabilities 2016: $20,464Net Assets 2016: -$18,3292016Assets 2017: $13,255Liabilities 2017: $13,389Net Assets 2017: -$1342017Assets 2018: $8,846Liabilities 2018: $13,389Net Assets 2018: -$4,5432018Assets 2019: $4,785Liabilities 2019: $13,389Net Assets 2019: -$8,6042019Assets 2020: $2,915Liabilities 2020: $13,389Net Assets 2020: -$10,4742020Assets 2021: $11,995Liabilities 2021: $21,796Net Assets 2021: -$9,8012021Assets 2022: $70,401Liabilities 2022: $0Net Assets 2022: $70,4012022Assets 2023: $61,959Liabilities 2023: $0Net Assets 2023: $61,9592023Assets 2024: $74,172Liabilities 2024: $0Net Assets 2024: $74,1722024

Highlighted filing

2017

Assets$13,255
Liabilities$13,389
Net Assets-$134
Open 2017 Filing

Operations Trend

Revenue Growth86th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$300K$200K$100K$0-$100KRevenue 2013: $50,420Expenses 2013: $50,917Net Income 2013: -$4972013Revenue 2014: $88,448Expenses 2014: $55,215Net Income 2014: $33,2332014Revenue 2015: $62,746Expenses 2015: $78,927Net Income 2015: -$16,1812015Revenue 2016: $69,437Expenses 2016: $94,146Net Income 2016: -$24,7092016Revenue 2017: $106,375Expenses 2017: $88,180Net Income 2017: $18,1952017Revenue 2018: $150,951Expenses 2018: $155,360Net Income 2018: -$4,4092018Revenue 2019: $100,450Expenses 2019: $104,511Net Income 2019: -$4,0612019Revenue 2020: $37,778Expenses 2020: $39,648Net Income 2020: -$1,8702020Revenue 2021: $31,688Expenses 2021: $31,015Net Income 2021: $6732021Revenue 2022: $215,926Expenses 2022: $135,724Net Income 2022: $80,2022022Revenue 2023: $38,186Expenses 2023: $46,628Net Income 2023: -$8,4422023Revenue 2024: $60,158Expenses 2024: $47,945Net Income 2024: $12,2132024

Highlighted filing

2017

Revenue$106,375
Expenses$88,180
Net Income$18,195
Open 2017 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Signed
Nov 12, 2018
Return Version
2017v2.2
Gross Receipts
$106,375
Mission and Program Overview

Mission

Research cancer treatment outcome

Program Services

DescriptionGrantsExpenses
The Gerson Research Organization provided substantial epidemiological services in 2017 to the CHIPSA Hospital, the Gerson Institute, and Batu Biologics. Forty-year retrospective melanoma survival study; data collection in collaboration with Gerson Institute, assessment in collaboration with Wayne Jonas (Samueli Foundation) and Cindy Crawford (Thought Leadership Innovation Foundation). Collection of outcomes data completed. Proceeding with array and assessment of data, and positioning for publication.Creation of tumor registry infrastructure, positions and database, within Gerson Institute.Systematic review of the oeuvre of Max Gerson with attention to ancillary literature.Translation of Diet Therapy of Pulmonary Tuberculosis by Max Gerson (424 of 619 pages to date). Introduction to CHIPSA owners of the concept of using the tuberculosis monograph as the basis of a syllabus and curriculum for a postdoctoral medical specialty. Advanced methodology with St Andrews Clinic physicians and nurses; taught the Danger Model of Matzinger and Fuchs in the context of tumor immunotherapy; implemented tuberculosis-diet principles as articulated by Gerson in his book My Diet. Continued patient education/informed consent.CHIPSA: Created a data-trapping system and basic tumor registry functions within CHIPSA. Created patient-education video lecture series on methods and materials of CHIPSA: https://www.facebook.com/chipsahospital/videos/1971748283110388/.Batu Biologics: Coordinated data collection for FDA/Ex-US/Phase 1 clinical trial of ValloVax. Established infrastructure for health information management/cancer information management (HIM/CIM) and dovetailed this with the above CHIPSA data-trapping system and tumor registry functions.$86,283-
Compensation and Service Providers
Top Officer Pay88th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
GAR HILDENBRANDPres/Exec DirectorFT$30,000$6,580$36,580
CHRISTEENE HILDENBRANDV.P./DirectorFT$0--
KAREN COOK DCDirector-$0--
DANIELLE MICHAEL JAMESDirector-$0--
JOHN PATRICK MARTINDirector-$0--
Filing and Contact Details

Filer

Filer Name
Gerson Research Organization
EIN
33-0588751
Phone
8587746642
Address
7807 ARTESIAN ROAD, SAN DIEGO, CA 92127

Signing Officer

Name
Gar Hildenbrand
Title
President
Signed
2018-11-12
Discuss with paid preparer
Yes

Preparer

Firm
Benito & Company
Address
10801 Thornmint Road Suite 150, San Diego, CA 92127
Preparer
Mark Benito CPA
Phone
8584870777
Supplemental Narrative

Additional Explanations

Other Expenses.1002

“Office Expenses $4119”

Other Expenses.1005

“Travel $12587”

Other Expenses.1

“Education & research $20734”

Other Expenses.2

“TELEPHONE $4005”

Other Expenses.3

“TRANSLATION $1423”

Other Expenses.4

“PAYROLL SERVICE $1414”

Other Expenses.6

“FEES $360”

Other Expenses.7

“BANK CHARGES $231”

Total Liabilities.1006

“Payable to Officers, Directors, Etc. - Beginning $20464 Payable to Officers, Directors, Etc. - Ending $13389”

Raw XML Appendix146 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0CHRISTEENE HILDENBRAND
IRS990EZ/BooksInCareOfDetail/PhoneNum08587592476
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt07807 ARTESIAN ROAD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SAN DIEGO
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092127
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt02135
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt013255
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt097275
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt018195
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt0565
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form720FiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt02135
IRS990EZ/Form990TotalAssetsGrp/EOYAmt013255
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrossReceiptsAmt0106375
IRS990EZ/GrossReceiptsForPublicUseAmt00
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InitiationFeesAndCapContriAmt00
IRS990EZ/LoansToFromOfficersAmt013389
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0true
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0-18329
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0-134
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0-18329
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0-134
IRS990EZ/OccupancyRentUtltsAndMaintAmt02447
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt070.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt170.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt030000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt06580
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0GAR HILDENBRAND
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1CHRISTEENE HILDENBRAND
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2KAREN COOK DC
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3DANIELLE MICHAEL JAMES
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4JOHN PATRICK MARTIN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRES/EXEC DIR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1V.P./DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4DIRECTOR
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationFiled990TInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt044873
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0RESEARCH CANCER TREATMENT OUTCOME
IRS990EZ/PrintingPublicationsPostageAmt01084
IRS990EZ/ProgramServiceRevenueAmt09100
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0The Gerson Research Organization provided substantial epidemiological services in 2017 to the CHIPSA Hospital, the Gerson Institute, and Batu Biologics. Forty-year retrospective melanoma survival study; data collection in collaboration with Gerson Institute, assessment in collaboration with Wayne Jonas (Samueli Foundation) and Cindy Crawford (Thought Leadership Innovation Foundation). Collection of outcomes data completed. Proceeding with array and assessment of data, and positioning for publication.Creation of tumor registry infrastructure, positions and database, within Gerson Institute.Systematic review of the oeuvre of Max Gerson with attention to ancillary literature.Translation of Diet Therapy of Pulmonary Tuberculosis by Max Gerson (424 of 619 pages to date). Introduction to CHIPSA owners of the concept of using the tuberculosis monograph as the basis of a syllabus and curriculum for a postdoctoral medical specialty. Advanced methodology with St Andrews Clinic physicians and nurses; taught the Danger Model of Matzinger and Fuchs in the context of tumor immunotherapy; implemented tuberculosis-diet principles as articulated by Gerson in his book My Diet. Continued patient education/informed consent.CHIPSA: Created a data-trapping system and basic tumor registry functions within CHIPSA. Created patient-education video lecture series on methods and materials of CHIPSA: https://www.facebook.com/chipsahospital/videos/1971748283110388/.Batu Biologics: Coordinated data collection for FDA/Ex-US/Phase 1 clinical trial of ValloVax. Established infrastructure for health information management/cancer information management (HIM/CIM) and dovetailed this with the above CHIPSA data-trapping system and tumor registry functions.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt086283
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/RelatedOrgSect527OrgInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt039211
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt020464
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt013389
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt088180
IRS990EZ/TotalProgramServiceExpensesAmt086283
IRS990EZ/TotalRevenueAmt0106375
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/WebsiteAddressTxt0N/A
IRS990ScheduleA/HospitalInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt013389
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt0ADVANCE
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt020464
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0GAR HILDENBRAND
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0PRESIDEN
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0false
IRS990ScheduleL/TotalBalanceDueAmt013389
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Office Expenses $4119
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Travel $12587
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2EDUCATION & RESEARCH $20734
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3TELEPHONE $4005
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4TRANSLATION $1423
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5PAYROLL SERVICE $1414
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6FEES $360
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7BANK CHARGES $231
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt8Payable to Officers, Directors, Etc. - Beginning $20464 Payable to Officers, Directors, Etc. - Ending $13389
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Expenses.1002
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Other Expenses.1005
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Other Expenses.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Other Expenses.3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Other Expenses.4
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6Other Expenses.6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7Other Expenses.7
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc8Total Liabilities.1006
ReturnHeader/BuildTS02019-02-21 02:37:17Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0GAR HILDENBRAND
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President
ReturnHeader/BusinessOfficerGrp/SignatureDt02018-11-12
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0GERSON RESEARCH ORGANIZATION
ReturnHeader/Filer/BusinessNameControlTxt0GERS
ReturnHeader/Filer/EIN0330588751
ReturnHeader/Filer/PhoneNum08587746642
ReturnHeader/Filer/USAddress/AddressLine1Txt07807 ARTESIAN ROAD
ReturnHeader/Filer/USAddress/CityNm0SAN DIEGO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092127
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0330739062
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Benito & Company
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt010801 Thornmint Road Suite 150
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0San Diego
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd092127
ReturnHeader/PreparerPersonGrp/PhoneNum08584870777
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0MARK BENITO CPA
ReturnHeader/ReturnTs02018-11-12T09:35:44-08:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02017-01-01
ReturnHeader/TaxPeriodEndDt02017-12-31
ReturnHeader/TaxYr02017

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2017 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$13,255
Liabilities
$13,389
Net assets
-$134
Revenue
$106,375
Expenses
$88,180
Net income
$18,195
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$0.74$0.00$0.74$0.60$0.48$0.12
2023Detailed filing. Detailed filing data is available for this year.$0.62$0.00$0.62$0.38$0.47$0.08
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.70$0.00$0.70$2.16$1.36$0.80
2021Detailed filing. Detailed filing data is available for this year.$0.12$0.22$0.10$0.32$0.31$0.01
2020Detailed filing. Detailed filing data is available for this year.$0.03$0.13$0.10$0.38$0.40$0.02
2019Detailed filing. Detailed filing data is available for this year.$0.05$0.13$0.09$1.00$1.05$0.04
2018Detailed filing. Detailed filing data is available for this year.$0.09$0.13$0.05$1.51$1.55$0.04
2017Detailed filing. Detailed filing data is available for this year.$0.13$0.13$0.00$1.06$0.88$0.18
2016Detailed filing. Detailed filing data is available for this year.$0.02$0.20$0.18$0.69$0.94$0.25
2015Detailed filing. Detailed filing data is available for this year.$0.19$0.13$0.06$0.63$0.79$0.16
2014Detailed filing. Detailed filing data is available for this year.$0.36$0.13$0.23$0.88$0.55$0.33
2013Detailed filing. Detailed filing data is available for this year.$0.02$0.13$0.11$0.50$0.51$0.00